Allergan's CEO and CFO Affirm the Accuracy of Its Financial Reports.

Business Editors

IRVINE, Calif.--(BUSINESS WIRE)--Aug. 13, 2002

Allergan's (NYSE:AGN) Chairman of the Board, President and Chief Executive Officer David E.I. Pyott and Allergan's Corporate Vice President and Chief Financial Officer Eric K. Brandt, by certification letter to the U.S. Securities and Exchange Commission (SEC), today affirmed the accuracy of Allergan's Form 10-K report for 2001; Form 10-Q reports for the first and second quarters of 2002; Allergan's 2002 proxy statement to stockholders and other recent filings. These actions are in response to a June 27, 2002 order by the SEC requiring 947 companies to certify the accuracy of their financial reports. Additionally, accompanying Allergan's Report on Form 10-Q for the second quarter of 2002, Messrs. Pyott and Brandt, in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, certified that the Form 10-Q fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Allergan.

About Allergan, Inc.

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives.